23 May 2013
Keywords: maze, study, shows, inadequate, use, migraine-specific, medicines
Article | 13 September 2004
According to the results of the fourth phase of the MAZE (Migraine andZolmitriptan Evaluation) survey presented at the European Federation ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 September 2004
22 May 2013
© 2013 thepharmaletter.com